Principles of Food Toxicology Flashcards
(91 cards)
1
Q
Define: food toxicology.
A
- The study of the adverse effects of substances present in foods on living organisms.
2
Q
Food toxicology is a scientific discipline that studies: [5]
A
- The nature, sources, and formation of toxic substances in foods
- The deleterious effects on consumers (chemical, not physical)
- The mechanisms and manifestations of these effects
- The identification of limits of safety
- Regulation of the use of these substances
3
Q
What are the categories of toxicants? [6]
A
- Foodborne and pathogenic microorganisms
- Nutritional factors (looking at diet, not necessarily food; concerned with nutrient quality not the food matrix)
- Naturally occurring toxicants
- Reaction products (typically generated from heat - e.g., advanced pyrolysis)
- Food additives
- Environmental contaminants (pesticides; plasticizers with estrogenic-like activity that act like endocrine disrupters)
4
Q
Food toxicology is a multidisciplinary field dealing with DOPER. Define this acronym: [5]
A
- Detection - note that detection requires release of the compound from the food matrix where the toxicant may be bound to PRO/CHO/FAT
- Occurrence
- Properties
- Effects - depends on biotransformation of the toxin (may cause a muted or enhanced effect); may accumulate
- Regulations
DOPER
5
Q
What is the exposure phase? [3]
A
- Disintegration of dose form
- Dissolution of active substance
- Available for absorption
6
Q
What is the toxicokinetic phase? [3]
A
- Absorption & distribution
- Metabolism & excretion
- Toxicant available for action
7
Q
What is the toxodynamic phase? [3]
A
- Toxicant-receptor
- Interaction in target tissue
- Biological effect
Relates to action mechanism.
8
Q
To construct a decision tree, consider the following: [4]
A
- The chemical agent capable of causing a deleterious response (e.g., defined as toxicant, poison)
- A biological system with which the chemical agent interacts to produce a deleterious effect
- A mechanism of interacting between chemical agent and biological system (e.g., receptor site)
- A response that can be used to quantitate the deleterious effect on the biological system (e.g., measureable biomarker)
9
Q
Define: toxicant.
A
A substance or chemical compound that has an [adverse] effect on organisms
10
Q
Define: toxic
A
When the substance causes cellular or tissue injury by mechanisms other than physical trauma (i.e., chemical)
11
Q
Define: toxicity.
A
- The capacity of a substance to cause adverse health effects on a living organism.
- The capacity to produce toxic injury to cells or tissues.
12
Q
Define: hazard
A
- The likelihood of a substance to cause harm.
- The probability that harm or injury will result when the substance is used in a proposed manner and quantity.
Risk x probability = hazard
13
Q
What are the effects of toxicants? [4]
A
- Physiological damage
- Carcinogenesis
- Mutagenesis (may lead to induction of cancer)
- Teratogenesis
14
Q
Define: Physiological damage
A
Reversible/irreversible damage to the health of the organism
15
Q
Define: carcinogenesis
A
Induction of cancer
16
Q
Define: mutagenesis
A
Induction of genetic damage/mutation
17
Q
Define: teratogenesis
A
Induction of birth defects
18
Q
- The study of the adverse effects of substances present in foods on living organisms.
A
Define: food toxicology.
19
Q
A substance or chemical compound that has a negative effect on organisms
A
Define: toxicant.
20
Q
When the substance causes cellular or tissue injury by mechanisms other than physical trauma.
A
Define: toxic
21
Q
- The capacity of a substance to cause adverse health effects on a living organism.
- The capacity to produce toxic injury to cells or tissues.
A
Define: toxicity.
22
Q
- The likelihood of a substance to cause harm.
- The probability that harm or injury will result when the substance is used in a proposed manner and quantity.
A
Define: hazard
23
Q
Reversible/irreversible damage to the health of the organism
A
Define: Physiological damage
24
Q
Induction of cancer
A
Define: carcinogenesis
25
Induction of genetic damage/mutation
Define: mutagenesis
26
Induction of birth defects
Define: teratogenesis
27
Describe the JECFA procedure for the evaluation of flavouring substances considered to be metabolised to innocuous products.
28
How is half life determined (single dose)?
* After receiving a single dose of toxicant, blood is taken at different times thereafter to detect toxicant concentration (take 6 - 10 samples)
* The **toxicant concentration (log) versus time** is plotted and a line can be obtained via **first order kinetics**
29
What is the significance of T1/2?
* It reflects rate of excretion, biotransformation and accumulation for a toxicant in the body.
* A long half-life corresponds to slow elimination and greater potential for accumulation and overall toxicity.
30
31
32
What is the dose-response relationship?
* The dose makes the poison
* All substances are poisons; there are none which are not a poison.
* The amount of chemical (dose) a person is exposed to is important in determining the extent of toxicity that will occur.
33
What 4 important values are important when finding a compromise between a dose/exposure ratio that is safe, yet therapeutically effective?
* Potency
* Efficacy
* Slope (rate)
* Variability
34
Describe how to determine potency and efficacy on a dose response curve.
* Toxin X has greater biologic activity per dosing equivalent and is thus **more potent** than Toxin Y or Z.
* Toxins X and Z have **equal efficacy**, indicated by their maximal attainable response (ceiling effect).
* Toxin Y is **more potent** than Toxin Z, but the **maximal efficacy is lower**.
35
Define: ceiling effect.
Maximal attainable response
36
Maximal attainable response
Define: ceiling effect.
37
Describe the potency and efficacy of these toxins.
* Toxin X has greater biologic activity per dosing equivalent and is thus **more potent** than Toxin Y or Z.
* Toxins X and Z have **equal efficacy**, indicated by their maximal attainable response (ceiling effect).
* Toxin Y is **more potent** than Toxin Z, but the **maximal efficacy is lower**.
38
Substance A
39
What does the dose-response curve determine?
* The starting dose in an initial human trial designed to set guidelines for use.
40
What is the LD50 value?
* The median lethal dose or the amount of toxin necessary to kill 50% of experimental animals.
* Value indicates the degree of toxicity of substances.
* Values used to compare relative acute toxicity.
* Values less than 500 mg/kg indicate high toxicity; 1g/kg moderate; 2g/kg low toxicity.
41
What are the LD50 values for high, moderate, and low toxicity.
* High < 500 mg/kg
* Moderate < 1 g/kg
* Low < 2 g/kg
42
Give the estimate toxicity of common products.
43
Describe types of exposure and levels of effects.
44
Define acute level of effect.
* Dose: high
* Time of exposure: a few days
45
Define subacute level of effect.
* Dose: moderate
* Time of exposure: a month
46
Define subchronic level of effect.
* Dose: low
* Time of exposure: 1-3 months
47
Define chronic level of effect.
* Dose: very low
* Time of exposure: >3 months
48
Toxicokinetics is associated with exposure assessment.
True or False?
True.
49
Toxicokinetics is associated with risk assessment.
True or False?
False.
50
Toxicodynamics is associated with risk assessment.
True or False?
True.
51
Toxicodynamics is associated with exposure assessment.
True or False?
False.
## Footnote
Susceptibility factors are very specific to individuals and why such a range of responses in a population from the same dose of a toxin exist.
52
What is toxicokinetics?
Toxicokinetics is the **application of kinetic modelling** to determine the relationship between the systemic exposure of a compound in experimental animals and its toxicity.
## Footnote
a.k.a. the rate of change
53
How is toxicokinetics used to establish relationships between exposures of toxins in toxicology experiments in animals and corresponding exposures in humans?
* Toxicokinetics enables us to describe how the body handles toxicants as indicated by the plasma concentration of that xenobiotic over different times that describe the exposures.
* The end result of defining the toxicokinetic processes that are specific to each toxin gives information on the **biologically effective dose** of that toxicant
* Hence: The magnitude of the toxic effect will be a function of the concentration of altered molecular targets. This in turn is related to the concentration of the active form of the toxicant ( biologically effective dose) at the site where the molecular targets are located.
* We refer to this as the **Dose-Response Concept**.
## Footnote
Based on steady-state kinetics.
54
What is the dose-response concept?
* The magnitude of the toxic effect will be a function of the concentration of altered molecular targets.
* This in turn is related to the concentration of the active form of the toxicant ( biologically effective dose) at the site where the molecular targets are located.
## Footnote
Depends on the metabolic activity in the body.
55
What are the 2 toxicokinetic phases?
1) Distribution phase
2) Biotransformation phase
## Footnote
Backbone of understanding how the toxin behaves in the body to elicit the toxic effect.
56
What is the distribution phase?
* Toxins are transported and then may bind to the protein carriers or tissue compounds
## Footnote
Measured through direct concentration in plasma.
57
What is the biotransformation phase?
* **Cytochrome P-450 system**:
* phase 1 - activation (oxidation, reduction, hydrolysis)
* phase 2 - conjugation reactions (-OH, -SH, -NH2, & COOH)
* increased water solubility and ionization properties at physiological pH (enhanced secretion)
## Footnote
Measured by metabolite concentration in plasma.
58
What is toxicodynamics?
* Involves understanding how the molecular, biochemical, and physiological effects of a toxin, or their metabolite, interacts in a biological system.
59
How do we describe the interaction between the biologically active dose associated with active form of the toxin with a molecular, biochemical or physiological target?
## Footnote
Give examples of reactions [4], toxicological responses [3], and cellular/physiological outcomes [2].
## Footnote
Note that irreversible with repair is different from reversible - it depends on the situation. Think - teratogenicity for a fetus (= irreversible) compared to the same toxin exposure in an adult (= irreversible with repair).
60
Regarding physiological activities, what do we require models for? [4]
* **(1)** Absorption
* **(2)** Accumulation
* **(3)** Biotransformation/metabolism
* **(4)** Excretion
* **(a)** Gastrointestinal excretion (biliary; entero-hepatic circulation)
* **(b)** Urinary excretion (glomerular filtration; trans-tubular secretion) - these are related to biotransformation because the parent compound is too small to be eliminated, but the biotransformed compound is large enough
## Footnote
Note that elimination of toxins is enhanced by soy proteins (compared to milk protein) because the peptides from soy digestion interfere with entero-hepatic reabsorption.
61
What is absorption of toxicants and how are its characteristics assessed?
* The process by which toxicants cross the epithelial cell barrier and enter into the blood circulation
* The characteristics of this will be assessed using rate constants (e.g., ka = rate constant for absorption)
62
Factors that will influence the kinetic distribution of a toxicant include [3]:
* Route of exposure (e.g., oral usually takes longer than inhalation)
* Mechanism of absorption
* Chemical and physical properties of the toxicant
63
List 4 routes of exposure.
* Percutaneous (skin)
* Respiratory
* **Gastrointestinal (through diet or air swallowing)**
* Parenteral (injections)
64
Describe the GI tract as a route of exposure.
Absorption of food toxicants can take place anywhere, but much of the tissue structure in the digestion system is specially designed for absorption.
64
List 4 mechanisms of intestinal absorption.
* Passive diffusion
* Facilitated transport
* Active transport
* Pinocytosis
## Footnote
Most common in food toxicology are passive diffusion and facilitated transport.
65
Describe the most important/relevant type of absorption of toxicants via the GI tract.
* **Passive diffusion**
* Lipid-soluble substances pass through membranes more easily
66
Describe active transport in the GI tract.
* Requires expenditure of cellular energy
* Fundamental for excluding toxic compounds
* This mechanism is important in the **elimination of toxicants**
67
Which method of GI transport is fundamental for excluding toxic compounds?
Active transport
68
Describe facilitated transport in the GI tract.
* A form of passive transport facilitated by transport proteins
* Polar and non-polar molecules
69
Describe pinocytosis of the GI tract.
* Cell membrane wrap toxicants and draw them inside the cell
* High molecular weight and colloidal particles
70
List factors that affect absorption in the GI tract. [4]
* Blood flow
* Lymph flow rate
* Special biological inhibitors
* Properties of the toxicant
71
Describe how intestinal blood flow affects absorption in the GI tract.
* Normal blood flow in the portal vein 1.2 L/hr/kg
* This increases 30% after a meal!
* Toxicants which increase blood flow, may also have enhanced absorption and toxicity.
72
Describe how lymph flow rate affects absorption in the GI tract.
* Lymph flow rate is 2 mL/hr/kg
* Fats are absorbed and transported by lymph
* Highly toxic substances (e.g., botulinum toxin) are transported via this route
| Q: Does a high fat diet increase appearance rate of botulism symptoms?
## Footnote
A: Yes, because the spore is fat-soluble!
73
Describe the blood-brain barrier with regard to toxicant exposure.
* System with very low permeability to toxicants.
* Newborns do not have a completely developed barrier.
* Alcohol increases permeability of this barrier.
| Some toxins can still cross the blood-brain barrier (e.g., saxitoxins).
## Footnote
Newborns and alcoholics are higher risk.
74
Describe the placental barrier with regard to toxicant exposure.
* Substrate flux (e.g., glucose)
* Can inhibit (restrict) entrance of toxins to the fetus
* Radiation; lipid-soluble toxicants; organophosphorus insecticides can cross the barrier
75
What is able to cross the placental barrier? [3]
* Radiation
* Lipid-soluble toxicants
* Organophosphorus insecticides
76
Rate of absorption of a toxicant is higher in the GI tract when: [3]
* Rate of absorption is higher if toxicant is:
* more lipid-soluble
* greatest concentration
* smaller molecular weight
77
Describe where the accumulation of food toxicants occurs in the body.
* Organs (liver and kidneys)
* Lipid rich tissues (e.g., DDT and PCBs pass into the blood by fatty tissues)
* Bones (e.g., fluoride; lead; radium; tetracyclines [antibiotic])
* Other tissues (e.g., arsenic in keratin-rich tissues; iodine in thyroid glands; carbon monoxide in hemoglobin)
78
Where does biotransformation of toxicants occur?
Mainly in the liver, but also in the intestine, kidney, lung, brain, and skin.
79
What does metabolism of toxicants achieve?
* Decreases the biological activity
* Increase polarity (increased toxicant polarity enhances excretion)
## Footnote
Phase 1 and 2 need to be balanced or that could lead to enhanced toxicity. An example of this is in alcohol metabolism, since the balance is in favour of phase 1 enzymes, which produces a highly toxic compound that is then not eliminated as quickly as it is produced.
80
Describe biotransformation reactions of toxin versus nontoxic compounds.
81
Describe phase 1 and phase 2 enzymatic biotransformation reactions.
* **Phase 1 reactions**: decrease lipid solubility of the compound by introducing or exposing a functional group
* **Phase 2 reactions**: produce water-soluble conjugated products by combining compounds with endogenous substrates
82
List 3 examples of phase 1 enzymes responsible for biotransformation reactions.
* Cytochrome P450 (a group of non-specific enzymes)
* Monoamine oxidase
* Flavin-containing monooxygenase
## Footnote
Phase 1 reactions decrease lipid solubility of the compound by introducing or exposing a functional group. This may lead to a more toxic compound, or a non-toxic compound. The key is to maintain balance between phase 1 and 2 so that toxicity can be eliminated and does not accumulate during biotransformation.
83
List 2 examples of phase 2 enzymes responsible for biotransformation reactions.
* Glutathione-S-transferase
* Catechol-*O*-methyltransferase
## Footnote
Phase 2 reactions produce water-soluble conjugated products by combining compounds with endogenous substrates.
84
Give an example of phase 1 and 2 enzymatic biotransformation reactions for shellfish toxin.
* Phase 1: Cytochrome P450
* Phase 2: Glutathione-S-transferase
## Footnote
Enzymes require cofactors to function - usually a micronutrient. (e.g., Cytochrome needs iron; glutathione needs selenium). Diet is important! This is one of the variabilities in terms of susceptibility.
85
Give an example of phase 1 and 2 enzymatic biotransformation reactions for mycotoxins.
* Phase 1: Cytochrome P450
* Phase 2: Glutathione-S-transferase
## Footnote
Enzymes require cofactors to function - usually a micronutrient. (e.g., Cytochrome needs iron; glutathione needs selenium). Diet is important! This is one of the variabilities in terms of susceptibility.
86
Describe the excretion of water-soluble biotransformed products.
* Usually excreted in:
* Urine (molecular weights < 400)
* Bile (molecular weights >300)
87
Describe the excretion of volatile compounds (with high vapour pressure).
Excreted via the lungs
88
Describe the excretion of lipid-soluble compounds.
* Can leave the body as:
* Components of lactation fluid (e.g., aflatoxin M1)
* Dead skin cells
* Hair
* Saliva
* Reproductive tract secretions
89
Define the biological half-life of a toxicant.
The time required for some measure of the amount of a toxicant in the body (e.g. body burden, tissue concentration) to decrease to 1/2 its concentration value observed at the initiation of evaluation interval.
## Footnote
Relates to the sum of all the activities: absorption; distribution; biotransformation; elimination
90
Summarize the factors affecting distribution and excretion of toxicants & half-life. [10]
1) water compartments in the tissues of the body
2) lipid compartments in the tissues of the body
3) macromolecular binding
4) passage through the placenta
5) passage in the brain and cerebrospinal fluid
6) rate of pulmonary excretion
7) rate of renal excretion
8) rate of biliary excretion
9) rate of metabolism
10) lactation; perspiration; salivation; lachrymation (i.e., shedding tears); reproductive tract secretions
